Bayer expands Nubeqa in India as a treatment option without chemotherapy for men with metastatic hormone sensitive prostate cancer ‑sensitive prostate cancer
India, Feb 24: Bayer today announced that its cancer drug, Nubeqa® has lately received approval in India for an expanded…
